stanozolol has been researched along with Cold Fingers, Hereditary in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belch, JJ; Sturrock, RD | 1 |
Ayres, ML; Browse, NL; Jarrett, PE | 1 |
Falanga, V; Helfman, T | 1 |
Browse, NL; Jarrett, PE; Morland, M | 1 |
Holland, CD; Illingworth, K; Jayson, MI; Keegan, A; Taylor, L | 1 |
Menon, IS | 1 |
Bielawiec, M; MyĆliwiec, M; Perzanowski, A | 1 |
2 review(s) available for stanozolol and Cold Fingers, Hereditary
Article | Year |
---|---|
Raynaud's syndrome: current trends.
Topics: Alprostadil; Epoprostenol; Humans; Plasma Exchange; Prostaglandins E; Raynaud Disease; Stanozolol; Sympathectomy; Vasodilator Agents | 1983 |
Stanozolol as a novel therapeutic agent in dermatology.
Topics: Angioedema; Fibrinogens, Abnormal; Humans; Leg Dermatoses; Raynaud Disease; Scleroderma, Localized; Skin Diseases; Stanozolol; Urticaria | 1995 |
1 trial(s) available for stanozolol and Cold Fingers, Hereditary
Article | Year |
---|---|
A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis.
Topics: Adult; Double-Blind Method; Female; Fibrinolysis; Humans; Male; Raynaud Disease; Regional Blood Flow; Scleroderma, Systemic; Stanozolol | 1991 |
4 other study(ies) available for stanozolol and Cold Fingers, Hereditary
Article | Year |
---|---|
Blood viscosity, Raynaud's phenomenon and the effect of fibrinolytic enhancement.
Topics: Adult; Blood Viscosity; Female; Fibrinogen; Fibrinolysis; Hand; Hematocrit; Humans; Male; Middle Aged; Raynaud Disease; Regional Blood Flow; Scleroderma, Systemic; Stanozolol | 1981 |
Treatment of Raynaud's phenomenon by fibrinolytic enhancement.
Topics: Adult; Aged; Blood Flow Velocity; Body Temperature; Female; Fibrinolysis; Hand; Humans; Male; Middle Aged; Raynaud Disease; Stanozolol | 1978 |
The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
Topics: Administration, Oral; Adult; Amenorrhea; Anticoagulants; Behcet Syndrome; Drug Therapy, Combination; Ethylestrenol; Female; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Phenformin; Phlebitis; Raynaud Disease; Skin Diseases; Stanozolol; Thromboembolism; Thrombophlebitis; Varicose Ulcer | 1972 |
The influence of some drugs on platelet aggregation and adhesion.
Topics: Administration, Oral; Adult; Aged; Arteriosclerosis Obliterans; Coronary Disease; Densitometry; Drug Therapy, Combination; Esters; Female; Fibrinolysis; Humans; Male; Middle Aged; Nicotinic Acids; Phenformin; Platelet Adhesiveness; Raynaud Disease; Serum Globulins; Solubility; Stanozolol; Theophylline; Thromboangiitis Obliterans | 1972 |